SCHEMBL752343

SCHEMBL752343

C[C@@H](c1cc(Oc2ccc(Cl)c(C(=O)O)c2)ccc1Cl)[C@](O)(c1ccc(=O)n(C)c1)C(F)(F)F

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.34
TTR P02766 1/20 0.34
PPOX P50336 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MRGPRX4 Q96LA9 1/20 0.32
SCN8A Q9UQD0 1/20 0.32
SCN10A Q9Y5Y9 1/20 0.32
THRA P10827 1/20 0.32
THRB P10828 1/20 0.32
NPC1 O15118 1/20 0.32
MAPT P10636 1/20 0.32
RAB9A P51151 1/20 0.32
FFAR1 O14842 2/20 0.31
NR3C1 P04150 4/20 0.31
ADRB1 P08588 1/20 0.31
ADRB3 P13945 1/20 0.31
PTGER4 P35408 1/20 0.31
HTR2A P28223 1/20 0.31
SLC6A4 P31645 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL733020 1.00 MEN1 (0.34) MEN1TTRPPOXKMT2ATDP1
SCHEMBL734137 0.94 MRGPRX4 (0.34) MEN1TTRPPOXKMT2ATDP1
SCHEMBL753316 0.94 MRGPRX4 (0.34) MEN1TTRPPOXKMT2ATDP1
SCHEMBL480085 0.94 S1PR2 (0.34) MEN1TTRPPOXKMT2ATDP1
SCHEMBL753070 0.94 S1PR2 (0.34) MEN1TTRPPOXKMT2ATDP1
SCHEMBL732524 0.92 P2RX3 (0.34) MEN1TTRPPOXKMT2ATDP1
SCHEMBL754912 0.92 P2RX3 (0.34) MEN1TTRPPOXKMT2ATDP1
SCHEMBL752328 0.89 BAZ2B (0.43) KMT2AMRGPRX4MAPTBRD4BAZ2B
SCHEMBL480366 0.89 BAZ2B (0.43) KMT2AMRGPRX4MAPTBRD4BAZ2B
SCHEMBL734909 0.87 S1PR2 (0.34) MEN1TTRPPOXKMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411361-B1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2014-06-18 EP disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
WO-2010108902-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 MEN1 1173/4885TTR 731/4885PPOX 2714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.